Mitochondrial Alterations near Amyloid Plaques in an Alzheimer's Disease Mouse Model

While accumulation of amyloid-β (Aβ) deposited as senile plaques is a hallmark feature of Alzheimer's disease (AD), the neurotoxicity of these deposits remains controversial. Recent in vitro studies suggested a link between elevated Aβ and mitochondrial dysfunction that might contribute to the pathogenesis of AD. However, the in vivo evidence for mitochondria dysfunction caused by Aβ is still missing. Using intravital multiphoton imaging with a range of fluorescent markers, we systematically surveyed mitochondrial structural and functional changes in AD mouse models. We observed severe impairments to be limited to the vicinity of Aβ plaques, which included reduction of both numbers and membrane potential of mitochondria and the emergence of dystrophic and fragmented mitochondria. Both neuronal soma and neurites with oxidative stress show severe alterations in mitochondrial membrane potential in amyloid precursor protein mice. These results provide in vivo evidence revealing Aβ plaques as focal sources of toxicity that lead to severe structural and functional abnormalities in mitochondria. These alterations may contribute to neuronal network dysfunction and warrant further investigation as possible targets for therapeutic intervention in AD.

[1]  S. Remington,et al.  Redox-sensitive green fluorescent protein: probes for dynamic intracellular redox responses. A review. , 2008, Methods in molecular biology.

[2]  Jaime Grutzendler,et al.  Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches , 2004, Nature Neuroscience.

[3]  J. Blass,et al.  Abnormalities of mitochondrial enzymes in Alzheimer disease , 1998, Journal of Neural Transmission.

[4]  D. Chan Mitochondria: Dynamic Organelles in Disease, Aging, and Development , 2006, Cell.

[5]  Robert B. Petersen,et al.  Mitochondrial abnormalities in Alzheimer disease , 2000, Neurobiology of Aging.

[6]  M. Mattson,et al.  Impairment of Glucose and Glutamate Transport and Induction of Mitochondrial Oxidative Stress and Dysfunction in Synaptosomes by Amyloid β‐Peptide: Role of the Lipid Peroxidation Product 4‐Hydroxynonenal , 1997, Journal of neurochemistry.

[7]  H. Fukui,et al.  The mitochondrial impairment, oxidative stress and neurodegeneration connection: reality or just an attractive hypothesis? , 2008, Trends in Neurosciences.

[8]  D. Holtzman,et al.  Ultrastructural studies in APP/PS1 mice expressing human ApoE isoforms: implications for Alzheimer's disease. , 2012, International journal of clinical and experimental pathology.

[9]  Brian J. Bacskai,et al.  Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease , 2006, Neurobiology of Disease.

[10]  M. Duchen,et al.  β-Amyloid Peptides Induce Mitochondrial Dysfunction and Oxidative Stress in Astrocytes and Death of Neurons through Activation of NADPH Oxidase , 2004, The Journal of Neuroscience.

[11]  M. Sekutowicz,et al.  Rapid cell death is preceded by amyloid plaque-mediated oxidative stress , 2013, Proceedings of the National Academy of Sciences.

[12]  W. Parker,et al.  Cytochrome Oxidase Deficiency in Alzheimer's Disease a , 1991, Annals of the New York Academy of Sciences.

[13]  Reham M. Abdel-Kader,et al.  Mitochondrial Dysfunction—A Pharmacological Target in Alzheimer's Disease , 2012, Molecular Neurobiology.

[14]  Xi Chen,et al.  Materials and Methods Som Text Figs. S1 and S2 Table S1 References Abad Directly Links A␤ to Mitochondrial Toxicity in Alzheimer's Disease , 2022 .

[15]  D. Davies,et al.  Neurodegenerative Changes Associated with β-Amyloid Deposition in the Brains of Mice Carrying Mutant Amyloid Precursor Protein and Mutant Presenilin-1 Transgenes , 2001, Experimental Neurology.

[16]  T. Crombleholme,et al.  Optimized large-scale production of high titer lentivirus vector pseudotypes. , 2004, Journal of virological methods.

[17]  M. Mattson,et al.  Amyloid beta-peptide induces apoptosis-related events in synapses and dendrites. , 1998, Brain research.

[18]  G. Schultz,et al.  Positive effects of pollution? , 1996, Nature.

[19]  M. Mattson,et al.  Mitochondria in Neuroplasticity and Neurological Disorders , 2008, Neuron.

[20]  S. Perry,et al.  Mitochondrial membrane potential probes and the proton gradient: a practical usage guide. , 2011, BioTechniques.

[21]  S. Lipton,et al.  Glutamate-induced neuronal death: A succession of necrosis or apoptosis depending on mitochondrial function , 1995, Neuron.

[22]  M. Beal,et al.  Oxidative damage in Alzheimer's , 1996, Nature.

[23]  R. Tsien,et al.  Imaging Dynamic Redox Changes in Mammalian Cells with Green Fluorescent Protein Indicators* , 2004, Journal of Biological Chemistry.

[24]  P. Reddy,et al.  Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease. , 2011, Human molecular genetics.

[25]  Xiongwei Zhu,et al.  Amyloid-β overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins , 2008, Proceedings of the National Academy of Sciences.

[26]  Brian J. Bacskai,et al.  Aβ Plaques Lead to Aberrant Regulation of Calcium Homeostasis In Vivo Resulting in Structural and Functional Disruption of Neuronal Networks , 2008, Neuron.

[27]  M L Walsh,et al.  Monitoring of relative mitochondrial membrane potential in living cells by fluorescence microscopy , 1981, The Journal of cell biology.

[28]  P. Reddy,et al.  Mitochondria-Targeted Antioxidant SS31 Prevents Amyloid Beta-Induced Mitochondrial Abnormalities and Synaptic Degeneration in Alzheimer’s Disease , 2012, Pharmaceuticals.

[29]  G. Perry,et al.  Increased Autophagic Degradation of Mitochondria in Alzheimer Disease , 2007, Autophagy.

[30]  D. Borchelt,et al.  Accelerated Amyloid Deposition in the Brains of Transgenic Mice Coexpressing Mutant Presenilin 1 and Amyloid Precursor Proteins , 1997, Neuron.

[31]  D. Nicholls Fluorescence measurement of mitochondrial membrane potential changes in cultured cells. , 2012, Methods in molecular biology.

[32]  I. Ferrer,et al.  Dystrophic neurites of senile plaques in Alzheimer’s disease are deficient in cytochrome c oxidase , 2008, Acta Neuropathologica.

[33]  P. T. Nguyen,et al.  Dendritic Spine Abnormalities in Amyloid Precursor Protein Transgenic Mice Demonstrated by Gene Transfer and Intravital Multiphoton Microscopy , 2005, The Journal of Neuroscience.

[34]  L. Mosconi,et al.  Brain glucose metabolism in the early and specific diagnosis of Alzheimer’s disease , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[35]  H. Möller,et al.  A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients , 2000, Neurobiology of Aging.

[36]  D. Holtzman,et al.  Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s disease , 2008, Nature.

[37]  P. Reddy,et al.  Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage. , 2011, Human molecular genetics.

[38]  Kristina D. Micheva,et al.  Oligomeric amyloid β associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques , 2009, Proceedings of the National Academy of Sciences.

[39]  Vishwanath T. Anekonda,et al.  Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics. , 2012, Biochimica et biophysica acta.

[40]  P. Cras,et al.  Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[41]  M. Mattson,et al.  Amyloid β-peptide induces apoptosis-related events in synapses and dendrites , 1998, Brain Research.

[42]  J. Quinn,et al.  Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. , 2006, Human molecular genetics.

[43]  R. Petersen,et al.  Mild cognitive impairment , 2006, The Lancet.

[44]  George Perry,et al.  The role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer’s disease , 2009, Journal of neurochemistry.

[45]  M. Poot,et al.  Efficacy of MitoTracker Green™ and CMXrosamine to measure changes in mitochondrial membrane potentials in living cells and tissues , 2004, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[46]  P. Reddy,et al.  Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease , 2009, Experimental Neurology.

[47]  G. Perkins,et al.  Mitochondrial fragmentation in neurodegeneration , 2008, Nature Reviews Neuroscience.

[48]  T. Smith,et al.  J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential. , 1991, Biochemistry.